Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report | Read

PUBLISHED ON: May 12, 2021 | Duration: 3 min, 04 sec

  
loading..
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
ALSO WATCH
The Biggest Stories Of June 23, 2021

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com